Author: News Room
The Chimpzee NFTs are finally on the horizon, with the whitelist event for presale participants on April 15th followed by the public launch on April 16th.Investors of the $CHMPZ token have been highly excited about the incoming NFTs over the past few weeks. They will allow holders to earn the maximum passive income through staking and an exclusive opportunity to win up to $10,000.00 USDT through a special promotion from this charity-focused ecosystem.Chimpzee is a Web3 ecosystem that allows its users to earn a passive income while positively contributing to the world by saving animals and the environment.Chimpzee Announces NFT…
A year after the failure of Credit Suisse, the Swiss government says UBS may have to find as much as $27 billion to absorb potential losses and protect taxpayers from ever having to bail out a major bank. Now, the giant Swiss lender is hitting back, saying its finances are robust and warning that the proposal could harm Switzerland’s standing as a global financial center. Speaking at the bank’s annual shareholder meeting Wednesday, UBS chairman Colm Kelleher said he was “seriously concerned” about current discussions that could force the bank to hold much more cash and other liquid assets. “Additional…
Check out the companies making headlines in midday trading: Boeing — The aerospace giant fell 1.5% even after noting that it burned through $3.9 billion in cash in the first quarter. The cash burn was lower than what analysts had feared. Boeing also posted an adjusted loss of $1.13 per share on revenue of $16.57 billion, beating the adjusted loss of $1.76 per share and revenue of $16.23 billion that analysts polled by LSEG had forecast. Tesla — Shares surged 9% despite the company’s weaker-than-expected first-quarter financial update, after CEO Elon Musk said Tesla plans to begin production of new…
We have a divided market, especially in tech. It was a major theme in the Club’s April Monthly Meeting . There are companies that everyone loves and companies everyone is on the fence about, and then the company that everyone hates. Let’s start with the beloved. I’m talking about Meta Platforms , which delivers earnings on Wednesday evening, as well as Alphabet and Microsoft , which are out late Thursday. Amazon is next week. META YTD mountain Meta Platforms YTD Meta has the biggest tailwind on Earth being dangled in front of it — the newly signed law that says…
Many borrowers currently struggling with student loan payments would benefit from enrolling in an income-driven repayment plan, according to a recent Student Debt Crisis Center (SDCC) survey. Roughly three out of four borrowers who make $75,000 or less annually and would benefit from the SAVE plan are not currently enrolled in the plan, the survey said. Moreover, 38% of these borrowers are at risk of defaulting on their student loan payments six months from now and could be missing an opportunity to find debt relief in existing programs. President Joe Biden’s Saving on Valuable Education (SAVE) plan could lower borrowers’ monthly payments…
Our goal here at Credible Operations, Inc., NMLS Number 1681276, referred to as “Credible” below, is to give you the tools and confidence you need to improve your finances. Although we do promote products from our partner lenders who compensate us for our services, all opinions are our own. The interest rate on a 30-year fixed-rate mortgage is 7.125% as of April 8, which is unchanged from Friday. Additionally, the interest rate on a 15-year fixed-rate mortgage is 6.125%, which is 0.125 percentage points higher than Friday. With mortgage rates changing daily, it’s a good idea to check today’s rate…
Aging takes its toll, even among the healthiest elders. We love our self-sufficiency. We don’t want to give it up. Nearly everyone asked says they want to stay at home for as long as possible. But staying at home without any help can be very dangerous. Safety Issues Here’s an example of an elder who is fiercely independent and wants to remain in her own home for life. But, she is taking serious safety risks every day. She has already had a few falls, luckily not sustaining any broken bones. Retired Executive (RE), age 78, lives alone in her large…
The Biden administration is preparing a new aid package for Ukraine that is expected to be worth around $1 billion, multiple sources familiar with the matter told CNN, and is set to be approved by President Joe Biden after the Senate passes a new foreign aid funding bill as soon as Tuesday afternoon. In briefings to Congress in recent weeks, administration officials have indicated that the US will likely send Ukraine long-range ATACMS, or Army Tactical Missile Systems, for the first time as part of the new aid package, three of the sources said. Last fall the US first sent Ukraine the midrange variant of the ATACMS missile system, which can reach about 100 miles, while the longer-range version can reach…
Tesla: The electric-car maker is expected to report a decline in profits, while its shares have declined almost 40 per cent so far this year to 44 cents a share and it continues to cut prices in an effort to stimulate waning demand for electric vehicles. Investors will be keen to learn more about its plans for its self-driving “robotaxis” and its progress on a cheaper electric car known as Model 2. Other companies: PepsiCo, Freeport McMoran, Halliburton, GE Aerospace, RTX, Lockheed Martin, NextEra Energy, UPS, Philip Morris, Spotify, General Motors and Kimberly-Clark are reporting earnings before the bell. Visa, Texas…
Shares in Moderna (NASDAQ:MRNA), maker of the breakthrough mRNA shot against Covid-19, jumped to a three-month high this month [April 2024] after its cancer vaccine showed promising results in an early-stage clinical trial for patients with head and neck cancer.[1] This bright spot might buoy the stock for a while. But it ignores the legal cloud hanging over the company — one that could hammer Moderna with a massive judgment. Just days before the cancer vaccine news, Moderna’s stock fell 4% after a U.S. judge ruled against the company on several claims in a patent dispute.[2] At issue is Moderna’s…
